Skip to main content
Clinical Trials/NCT02834143
NCT02834143CompletedNot Applicable

Evaluation of Diagnostic Criteria for Chronic Critical Limb Ischemia

Fondation Hôpital Saint-Joseph1 site in 1 country180 target enrollmentStarted: June 13, 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
180
Locations
1
Primary Endpoint
Assessent of change of The Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC)

Study Overview

Brief Summary

Chronic critical limb ischemia (CCI) is the most severe clinical form of occlusive arterial disease. Its prognosis is terrible, mortality estimated at 50% in five years. However there are no recent epidemiological data on morbidity and mortality of critical ischemia. Moreover, the diagnostic criteria of the ICC associate clinical and hemodynamic criteria and are not subject to a clear consensus.

Investigators propose to evaluate the validated diagnostic criteria (TASC VALMI, European working group) in a population of severe ischemia in patients in order to offer relevant simple and reproducible criteria. Secondly Investigators propose to monitor the medium and long term evolution of these patients ICC defined to clarify the prognosis.

diagnostic criteria of the different societies:

  • TASC: Transatlantic criteria: very characteristic pain, wound optional, variable hemodynamic criteria as the presence of a wound or not
  • VALMI: French criteria derived vascular medical college: characteristic pain, sore, hemodynamic reproducible, reliable criteria
  • European working group: European definition of criteria, including a characteristic pain, requires no wound, different hemodynamic criteria of 2 others.

Detailed Description

Main objective / secondary:

  • Main objective: Evaluation of diagnostic criteria for chronic critical limb ischemia

  • Secondary objectives:

  • Evaluation of the quality of life,

  • Evaluation of the need for psychological counseling a patient at the stage of chronic critical limb ischemia,

  • Evaluation of the interest of a specific bioassay

Development of the study:

The offer document and the non-opposition of the patient will be collected on the first day of hospitalization, quality of life questionnaires will also be distributed at the beginning of hospitalization.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All patients suffering from peripheral arterial disease of the lower limbs hospitalized in vascular medicine department of GHPSJ and having a life expectancy greater than one year.

Exclusion Criteria

  • demented patient psychological condition

Outcomes

Primary Outcomes

Assessent of change of The Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC)

Time Frame: Day 1, then Day 45 after hospitalization

Assessent of change of VALMI (French criteria derived vascular medical college)

Time Frame: Day 1, then Day 45 after hospitalization

French criteria derived vascular medical college: characteristic pain, sore, reproducible hemodynamic criteria, reliable

Assessent of change of the European working group criteria

Time Frame: Day 1, then Day 45 after hospitalization

European definition of criteria, including a characteristic pain, requires no wound, different haemodynamic criteria 2 others.

Secondary Outcomes

  • Assessent of quality of life(Day 1, then Day 45 after hospitalization)
  • Evaluation of the need for psychological counseling(Day 1, then Day 45 after hospitalization)
  • Evaluation of the interest of a specific bioassay(Day 1, then Day 45 after hospitalization)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials